Posada
Chrystian M. Posada, Rolla, MO US
Patent application number | Description | Published |
---|---|---|
20150311023 | METHOD TO FABRICATE PORTABLE ELECTRON SOURCE BASED ON NITROGEN INCORPORATED ULTRANANOCRYSTALLINE DIAMOND (N-UNCD) - A source cold cathode field emission array (FEA) source based on ultra-nanocrystalline diamond (UNCD) field emitters. This system was constructed as an alternative for detection of obscured objects and material. Depending on the geometry of the given situation a flat-panel source can be used in tomography, radiography, or tomosynthesis. Furthermore, the unit can be used as a portable electron or X-ray scanner or an integral part of an existing detection system. UNCD field emitters show great field emission output and can be deposited over large areas as the case with carbon nanotube “forest” (CNT) cathodes. Furthermore, UNCDs have better mechanical and thermal properties as compared to CNT tips which further extend the lifetime of UNCD based FEA. | 10-29-2015 |
Eduardo Posada, Bogota D.c CO
Patent application number | Description | Published |
---|---|---|
20140162878 | SYNERGISTIC WEED CONTROL FROM APPLICATIONS OF AMINOCYCLOPYRACHLOR AND PICLORAM - Disclosed herein are herbicidal compositions comprising a synergistically herbicidal effective amount of (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) picloram, or an agriculturally acceptable salt or ester thereof. Also disclosed herein are methods of controlling undesirable vegetation, which comprise applying to vegetation or an area adjacent the vegetation or applying to soil or water to prevent the emergence or growth of vegetation (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) picloram, or an agriculturally acceptable salt or ester thereof, wherein (a) and (b) are each added in an amount sufficient to produce a synergistic herbicidal effect. | 06-12-2014 |
Eduardo Posada, Bogota CO
Patent application number | Description | Published |
---|---|---|
20140094365 | SYNERGISTIC WEED CONTROL FROM APPLICATIONS OF AMINOCYCLOPYRACHLOR AND TRICLOPYR - Disclosed herein are herbicidal compositions comprising a synergistically herbicidal effective amount of (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) triclopyr, or an agriculturally acceptable salt or ester thereof. Also disclosed herein are methods of controlling undesirable vegetation, which comprise applying to vegetation or an area adjacent the vegetation or applying to soil or water to prevent the emergence or growth of vegetation (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) triclopyr, or an agriculturally acceptable salt or ester thereof, wherein (a) and (b) are each added in an amount sufficient to produce a synergistic herbicidal effect. | 04-03-2014 |
20140094366 | SYNERGISTIC WEED CONTROL FROM APPLICATIONS OF AMINOCYCLOPYRACHLOR AND FLUROXYPYR - Disclosed herein are herbicidal compositions comprising a synergistically herbicidal effective amount of (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) fluoroxypyr, or an agriculturally acceptable salt or ester thereof. Also disclosed herein are methods of controlling undesirable vegetation, which comprise applying to vegetation or an area adjacent the vegetation or applying to soil or water to prevent the emergence or growth of vegetation (a) aminocyclopyrachlor, or an agriculturally acceptable salt or ester thereof, and (b) fluoroxypyr, or an agriculturally acceptable salt or ester thereof, wherein (a) and (b) are each added in an amount sufficient to produce a synergistic herbicidal effect. | 04-03-2014 |
Esmeralda Posada, Gent BE
Patent application number | Description | Published |
---|---|---|
20110296552 | EXPRESSION CASSETTES FOR SEED-SPECIFIC EXPRESSION IN PLANTS - The present invention relates to materials and methods for the expression of a gene of interest specifically in seeds of plants, even more specifically in oilseed plants. In particular, the invention provides an expression cassette for regulating seed-specific expression in plants. | 12-01-2011 |
Lucas Posada, Montreal CA
Patent application number | Description | Published |
---|---|---|
20150119743 | Piezoelectric Beam Bending Actuated Device for Measuring Respiratory System Impedance - An actuator ( | 04-30-2015 |
Luciano Posada, Montreal CA
Patent application number | Description | Published |
---|---|---|
20140170604 | COLORING SYSTEM AND MANUFACTURING PROCESS FOR ARTIFICIAL COVERING STONES - A coloring system and a manufacturing process for coloring artificial covering stones are provided. A board layout represents a board of artificial covering stones. Several natural stone color patterns are provided, each being different from one another. The natural stone color patterns are associated with selected artificial stones of the board layout. Graphic parameters represent the natural stone color and are converted into coloring instructions. A conveyor conveys the board of artificial covering stones, and a positioning system determines respective positions of the artificial covering stones of the board, relative to a reference position. An in-line coloring device colors the artificial covering stones with the natural stone patterns, according to the coloring instructions and to the positions of the artificial stones. The selected artificial stones colored by the system are thus different from other stones of the board, and have a distinct, natural random-look. | 06-19-2014 |
Miguel Abal Posada, Santiago De Compostela ES
Patent application number | Description | Published |
---|---|---|
20150290245 | AGENT, PRODUCT AND USE - The present invention relates to a composition for modulating tumor cell dissemination, in particular metastatic cancer cells. In particular, the invention relates to an agent for modulating metastatic tumor cell dissemination for use in the treatment and/or prevention of a metastatic cancer wherein the agent is a capture agent and/or a chemoattractant for tumor cells. The invention also relates to a product, comprising an agent for modulating metastatic kidneys tumor cell dissemination, and to a method of treatment or prevention of cancer. | 10-15-2015 |
Miguel Abal Posada, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20120122726 | MARKERS FOR ENDOMETRIAL CANCER - The invention relates to the surprising finding that biomarkers corresponding to ACAA1, AP1M2, CGN, DDR1, EPS8L2, FASTKD1, GMIP, IKBKE, P2RX4, P4HB, PHKG2, PPFIBP2, PPP1 R16A, RASSF7, RNF183, SIRT6, TJP3, EFEMP2, S0CS2, and DCN are differentially expressed in control samples as compared to samples from patients having endometrial cancer and are therefore useful for detecting endometrial cancer. In particular these biomarkers having excellent sensitivity, specificity, and/or the ability to separate affected from non affected individuals. Furthermore, the inventors found that the differential expression of these biomarkers in primary endometrial cancer tumor tissue is correlated to their expression level in uterine fluid samples as compared to control values. Thus these biomarkers are robust in that they are found to be differentially expressed in several different types of samples from affected individuals. | 05-17-2012 |
20130171653 | METHODS AND KITS FOR THE DIAGNOSIS OF PROSTATE CANCER - The present invention relates to the use of PSGR, a member of the G-protein-coupled olfactory receptor family which is over-expressed in prostate cancer tissue, as a marker suitable for an urine-based diagnostic test for prostate cancer which require only typical prostate manipulation and sample acquisition scenarios avoiding invasive tissue collection. | 07-04-2013 |
20130178393 | METHODS AND KITS FOR THE DIAGNOSIS OF PROSTATE CANCER - The invention relates to methods and kits for the diagnosis of prostate cancer (PCa) in a subject, for assessing or monitoring the response to a therapy in a subject having PCa or for monitoring the progression of prostate cancer PCa based on the detection of alteration in the expression levels of at least one gene selected from the group of PC A3, PSMA and PSGR. The invention relates as well to methods for assessing whether a subject has to be subjected to a prostate biopsy, said subject having a serum PSA range within 4-10 ng/mL. | 07-11-2013 |
20150337392 | MARKERS FOR ENDOMETRIAL CANCER - The invention relates to the surprising finding that biomarkers corresponding to ACAA1, AP1M2, CGN, DDR1, EPS8L2, FASTKD1, GMIP, IKBKE, P2RX4, P4HB, PHKG2, PPFIBP2, PPP1R16A, RASSF7, RNF183, SIRT6, TJP3, EFEMP2, SOCS2, and DCN are differentially expressed in control samples as compared to samples from patients having endometrial cancer and are therefore useful for detecting endometrial cancer. In particular these biomarkers having excellent sensitivity, specificity, and/or the ability to separate affected from non affected individuals. Furthermore, the inventors found that the differential expression of these biomarkers in primary endometrial cancer tumor tissue is correlated to their expression level in uterine fluid samples as compared to control values. Thus these biomarkers are robust in that they are found to be differentially expressed in several different types of samples from affected and individuals. | 11-26-2015 |
Sol A. Posada, Cincinnati, OH US
Patent application number | Description | Published |
---|---|---|
20160058440 | Devices and Methods for Removably Coupling a Cartridge to an End Effector of a Surgical Device - Devices and methods are provided for removably coupling a cartridge to an end effector of a surgical device. In general, one of a cartridge and a surgical device can include at least one mating element, and the other of the cartridge and the surgical device can include at least one engagement feature configured to removably engage the at least one mating element. The engagement of the at least one mating element and the at least one engagement feature can help ensure that the cartridge is fully mated to the surgical device such that the surgical device can properly fire fasteners disposed within the cartridge. The engagement of the at least one mating element and the at least one engagement feature can be configured to provide a positive indication that the cartridge is fully seated in an end effector of the surgical device. | 03-03-2016 |
20160058447 | Methods and Devices for Locking a Surgical Device Based on Loading of a Fastener Cartridge in the Surgical Device - Devices and methods are provided for locking a surgical device based on loading of a fastener cartridge in the surgical device. In general, a surgical device can be configured to prevent at least one of closure of an end effector of the surgical device and firing of fasteners from the end effector when a cartridge is not fully seated in the end effector. In an exemplary embodiment, the surgical device can include a lockout element configured to prevent at least one of closure of the end effector and firing of fasteners from the end effector when a cartridge is not fully seated in the end effector. The locking element can be configured to automatically prevent firing and/or prevent closing of the end effector if a cartridge is not fully seated in the end effector. | 03-03-2016 |
20160066915 | POLARITY OF HALL MAGNET TO DETECT MISLOADED CARTRIDGE - A surgical stapling system including a shaft assembly transmits actuation motions from an actuator and an end effector compresses and staples tissue. The end effector comprises an channel; an anvil having a staple forming surface is moveable relative to the channel between open and closed positions; the anvil having a magnet at the distal end; and a staple cartridge removably positionable within the channel. The staple cartridge comprises a body supported for a confronting relationship with the anvil in its closed position; a plurality of staple drivers located within the cartridge body support a staple; a Hall effect sensor located at the distal end of the body; and a microprocessor in communication with the Hall effect sensor. The Hall effect sensor and microprocessor receive power when the staple cartridge is positioned within the channel, and the system is operable to identify the staple cartridge. | 03-10-2016 |